Life sciences firm doubling down on MoCo with $286M investment


The U.S. and Canadian life sciences arm of Germany’s Merck KGaA plans to expand its biosafety testing capacity and local headcount.

Previous Sharonview Federal Credit Union names chief revenue officer as its next CEO
Next CVS pharmacists are now prescribing Paxlovid directly to Covid-19 patients